Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 06/30/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 0.00% | -702.09% | -246.37% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -35.50% | 120.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 0.00% | -86.67% | 113.72% | 0.00% |
| Change in Net Operating Assets | 0.00% | 0.00% | 99.17% | -105.34% | 0.00% |
| Cash from Operations | 0.00% | 0.00% | -32.97% | -79.64% | 0.00% |
| Capital Expenditure | 0.00% | 0.00% | 70.69% | 50.07% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 0.00% | -59.79% | -53.97% | 0.00% |
| Cash from Investing | 0.00% | 0.00% | -52.64% | -55.39% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -6.88% | -4.95% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 0.00% | -33.14% | -16.50% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 0.00% | -376.67% | -173.84% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 0.00% | -586.16% | -247.45% | 0.00% |